Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 20,247 Shares of Waters Corporation $WAT

Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in Waters Corporation (NYSE:WAT) by 138.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 34,880 shares of the medical instruments supplier’s stock after purchasing an additional 20,247 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Waters were worth $10,387,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Zions Bancorporation National Association UT boosted its stake in Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 40 shares during the period. SHP Wealth Management bought a new position in Waters in the 4th quarter worth approximately $32,000. DV Equities LLC bought a new position in Waters in the 4th quarter worth approximately $32,000. Louisbourg Investments Inc. acquired a new position in shares of Waters during the first quarter worth approximately $30,000. Finally, North Star Investment Management Corp. lifted its holdings in shares of Waters by 10,200.0% during the first quarter. North Star Investment Management Corp. now owns 103 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 102 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on WAT shares. Bank of America raised their price objective on shares of Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 2nd. Robert W. Baird set a $387.00 target price on shares of Waters in a research note on Wednesday, May 6th. Evercore upgraded shares of Waters from an “in-line” rating to an “outperform” rating and set a $350.00 target price for the company in a research note on Monday, April 6th. HSBC increased their price target on shares of Waters from $415.00 to $435.00 and gave the company a “buy” rating in a report on Wednesday, June 3rd. Finally, Wells Fargo & Company boosted their price objective on shares of Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a report on Thursday, May 14th. Four investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $396.68.

Waters Price Performance

Shares of WAT stock opened at $378.62 on Friday. The stock has a 50 day moving average of $351.53 and a two-hundred day moving average of $347.02. The company has a current ratio of 1.79, a quick ratio of 1.13 and a debt-to-equity ratio of 0.32. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The company has a market capitalization of $37.18 billion, a P/E ratio of 48.11, a P/E/G ratio of 2.29 and a beta of 1.20.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. The business had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.Waters’s quarterly revenue was up 91.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. As a group, equities analysts expect that Waters Corporation will post 14.51 EPS for the current year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.